[1] Okruhlica L, Mihalkova A, Klempova D and Skovayova L. [J] Eur Addict Res, 2002, 8: 103. [2] Pataki I and Telegdy G. [J] Eur J Pharmacol, 1998, 357: 157. [3] Herman BH, Vocci F and Bridge P. [J] Neuropsychopharmacology, 1995, 13: 269. [4] Suzuki T, Takamori K, Misawa M and Onodera K. [J] Brain Res, 1995, 675: 195. [5] Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS and Tannenbaum SR. [J] Anal Biochem, 1982, 126: 131. [6] Katz RJ and Gormezano G. [J] Pharmacol Biochem Behav, 1979, 11: 213. [7] Drucker E and Vlahov D. [J] Lancet, 1999, 353: 1543. [8] Ohmori S, Fang L, Kawase M, Saito S and Morimoto Y. [J] Eur J Pharmacol, 2001, 423: 157. [9] Lue WM, Su MT, Lin WB and Tao PL. [J] Eur J Pharmacol, 1999, 383: 129. [10] Li SM, Yin LL, Shi J, Lin ZB and Zheng JW. [J] Eur J Pharmacol, 2002, 435: 217. [11] Lue WM, Su MT, Lin WB and Tao PL. [J] Eur J Pharmacol, 1999, 383: 129. [12] Malin DH, Lake JR, Shenoi M, Upchurch TP, Johnson SC, Schweinle WE and Cadle CD. [J] Psychopharmacology, 1998, 140: 371. [13] Virgili M, Monti B, LoRusso A, Bentivogli M and Contestabile A. [J] Brain Res, 1999, 839: 164. [14] Jaffe K and Blanco ME. [J] Pharmacol Biochem Behav, 1994, 47: 493. [15] Izzo E, Orsini C, Koob GF and Pulvirenti L. [J] Pharmacol Biochem Behav, 2001, 68: 701. [16] Kretschmer BD. [J] Brain Res, 2000, 859: 147. |